Dixit A, Bennett R, Ali K, Griffin C, et al. Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial. Lancet Infect Dis 2024 Mar 19:S1473-3099(24)00101.
PMID: 38518789